(63 days)
Not Found
Unknown
The summary mentions "proprietary software" used for image analysis to derive the implant design, which could potentially incorporate AI/ML, but it does not explicitly state or describe any AI/ML components or methodologies. Without further information about the "proprietary software," it's impossible to confirm.
Yes
This device is a knee replacement system intended to treat osteoarthritis and traumatic arthritis of the knee, which are medical conditions, thereby providing therapy.
No
Explanation: This device is a knee replacement system used to replace damaged articular surfaces, not to diagnose medical conditions. It uses patient imaging for personalized implant design but does not provide a diagnosis.
No
The device description clearly states that the system includes physical implants (femoral and tibial components made of CoCrMo and UHMWPE) and ancillary instrumentation, in addition to the software used for design.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The ConforMIS Unicondylar Knee Replacement System is a surgical implant designed to replace a damaged part of the knee joint. It is a physical device implanted into the body.
- Intended Use: The intended use is to replace damaged articular surfaces in the knee due to osteoarthritis or traumatic arthritis. This is a therapeutic intervention, not a diagnostic test performed on a specimen outside the body.
- Input: While the design process uses patient imaging (MRI or CT), this imaging is used to create a patient-specific implant, not to analyze a biological specimen for diagnostic purposes.
Therefore, the ConforMIS Unicondylar Knee Replacement System falls under the category of a surgical implant or prosthetic device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The ConforMIS Unicondylar Knee Replacement System (iUni) is intended for use in one compartment of the osteoarthritic knee to replace the damaged area of the articular surface in patients with evidence of adequate healthy bone sufficient for support of the implanted components.
Candidates for unicondylar knee replacement include those with:
- joint impairment due to osteoarthritis or traumatic arthritis of the knee,
- . previous femoral condyle or tibial plateau fracture, creating loss of function,
- valqus or varus deformity of the knee, .
- . revision procedures provided that anatomic landmarks necessary for alignment and positioning of the implant are identifiable on patient imaging scans.
This implant is intended for cemented use only.
Product codes (comma separated list FDA assigned to the subject device)
HSX, OOG
Device Description
ConforMIS iUni Unicondylar Knee Replacement System ("iUni KRS") is a patient-specific unicompartmental knee replacement system. The iUni is comprised of a set of implants designed from patient images. The implant system consist of:
- 1 Femoral Implant .
- 1 Tibial Component (all-polyethylene or metal backed)
The implants of the iUni KRS will be composed of individually packaged femoral and tibial components and will be provided with ancillary instrumentation to assist in the implantation procedure.
The patient-specific femoral implant will be made of Cobalt Chrome Molybdenum alloy (CoCrMo) and will be personalized to match a patient's anatomy.
The all poly tibial component is made from UHMWPE. The metal backed tibial component will consist of a CoCrMo tibial tray and with an Ultra High Molecular Weight Polyethylene (UHMWPE) tibial insert. Multiple inserts of varying thicknesses may be provided to accommodate surgeon preferences.
The outline bone contacting and articular surfaces of the femoral component as well as the outline of both tibial components are personalized to match the patient's femoral and tibial anatomy. The design of the implant is derived from an analysis, using proprietary software, of images obtained by MRI or CT scan.
Disposable, patient-specific instrumentation is provided to assist in the implantation of the iUni Unicondylar Knee Replacement System.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MRI or CT scan
Anatomical Site
Knee
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical laboratory testing was not performed as there is no change to the device. Clinical data is not necessary to demonstrate substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K111916, K092441, K072586, K072368, K063432, K043570, K102069, K033363
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3520 Knee joint femorotibial metal/polymer non-constrained cemented prosthesis.
(a)
Identification. A knee joint femorotibial metal/polymer non-constrained cemented prosthesis is a device intended to be implanted to replace part of a knee joint. The device limits minimally (less than normal anatomic constraints) translation in one or more planes. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral condylar resurfacing component or components made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components made of ultra-high molecular weight polyethylene and are intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
K121974 (1/4)
SEP 6 2012
5.0 510(K) SUMMARY (page 1 of 4)
t
.
.
.
.
・・ .
·
| Submitter's Name and Address | ConforMIS Inc.
11 North Ave.
Burlington, MA 01803 |
|-----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Establishment Registration Number | 3004153240 and 3008690421 |
| Date of Summary | July 03, 2012 |
| Contact Person | Amita S. Shah, Vice President, Quality Assurance and Regulatory Affairs |
| Telephone Number | (781) 345-9164 |
| Fax Number | (781) 345-0104 |
| Name of the Device | ConforMIS iUni Unicondylar Knee Replacement System |
| Common or Usual Name | Unicondylar Knee Replacement System |
| Classification Name | Prosthesis, knee, femorotibial, non-constrained, cemented, metal/polymerKnee Arthroplasty Implantation System |
| Regulation Number | 21 CFR 888.3520 |
| Device Classification | Product Code:
HSX - Knee joint femorotibial metal/polymer non-constrained cemented prosthesisOOG - Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis. Intended to be used to assist in the implantation of a specific knee arthroplasty device or a set of specific knee arthroplasty devices. Indicated to include guiding alignment, making or establishing cuts, |
implant components.
:
selecting, sizing, attaching, positioning or orienting
.
.
.
ન 8
1
510(K) SUMMARY (page 2 of 4)
Indications for Use
Indications for Use:
The ConforMIS Unicondylar Knee Replacement System (iUni) is intended for use in one compartment of the osteoarthritic knee to replace the damaged area of the articular surface in patients with evidence of adequate healthy bone sufficient for support of the implanted components.
Candidates for unicondylar knee replacement include those with:
- joint impairment due to osteoarthritis or traumatic . arthritis of the knee,
- . previous femoral condyle or tibial plateau fracture, creating loss of function,
- valqus or varus deformity of the knee, .
- . revision procedures provided that anatomic landmarks necessary for alignment and positioning of the implant are identifiable on patient imaging scans.
This implant is intended for cemented use only.
ldentification of the Legally Marketed Device (Predicate Device)
ConforMIS iUni Unicondylar Knee Replacement System Device Class: Product Code: HSX, OOG . Regulation Number: 21 CFR 888.3520 510(k) number: K111916, K092441, K072586, K072368, K063432, K043570
Smith & Nephew Journey Unicondylar Device Class: ll Product Code: HSX Regulation Number: 21 CFR 888.3520 K102069 510(k) number:
Zimmer Unicompartmental Knee System Device Class: Product Code: HSX Regulation Number: 21 CFR 888.3520 510(k) number: K033363
ન છ
2
510(K) SUMMARY (page 3 of 4)
Device Description
Substantial Equivalence: ConforMIS iUni Unicondylar Knee Replacement System ("iUni KRS") is a patient-specific unicompartmental knee replacement system. The iUni is comprised of a set of implants designed from patient images. The implant system consist of:
- 1 Femoral Implant .
- 1 Tibial Component (all-polyethylene or metal backed)
The implants of the iUni KRS will be composed of individually packaged femoral and tibial components and will be provided with ancillary instrumentation to assist in the implantation procedure.
The patient-specific femoral implant will be made of Cobalt Chrome Molybdenum alloy (CoCrMo) and will be personalized to match a patient's anatomy.
The all poly tibial component is made from UHMWPE. The metal backed tibial component will consist of a CoCrMo tibial tray and with an Ultra High Molecular Weight Polyethylene (UHMWPE) tibial insert. Multiple inserts of varying thicknesses may be provided to accommodate surgeon preferences.
The outline bone contacting and articular surfaces of the femoral component as well as the outline of both tibial components are personalized to match the patient's femoral and tibial anatomy. The design of the implant is derived from an analysis, using proprietary software, of images obtained by MRI or CT scan.
Disposable, patient-specific instrumentation is provided to assist in the implantation of the iUni Unicondylar Knee Replacement System.
The product subject of this premarket notification is substantially equivalent to the iUni Unicondylar Knee Replacement System (K111916 cleared September 29, 2011, K092441 cleared September 09, 2009, K072586 cleared November 08, 2007, K072368 cleared September 20, 2007, K063432 cleared March 16, 2007, and K043570 cleared March 14, 2005); Smith & Nephew Journey Unicondylar (K102069 cleared October 05, 2010); and Zimmer Unicompartmental Knee System (K033363 cleared January 16, 2004).
The purpose of this submission is to clarify the indications for use statement and make it consistent with predicate devices and FDA guidance.
20
3
510(K) SUMMARY (page 4 of 4)
Description and Conclusion of Testing The determination of substantial equivalence for this device was based on the indications for use statements and the device design. The design of the iUni KRS was previously determined to be substantially equivalent to predicate devices. A comparison of the designs and the indications for use statements confirmed that the modification to the indications for use does not affect device performance and is, therefore, also substantially equivalent.
Safety and Performance
Conclusion
The determination of substantial equivalence for this device was based on detailed device description and indications for use statement comparisons. Non-clinical laboratory testing was not performed as there is no change to the device. Clinical data is not necessary to demonstrate substantial equivalence.
Based on device description and indications for use statement comparisons, it is concluded that the ConforMIS iUni Unicondylar Knee Replacement System with the updated indications for use statement is substantially . equivalent to the iUni Unicondylar Knee Replacement System (K111916 cleared September 29, 2011, K092441 cleared September 09, 2009, K072586 cleared November 08, 2007, K072368 cleared September 20, 2007, K063432 cleared March 16, 2007, and K043570 cleared March 14, 2005); Smith & Nephew Journey Unicondylar (K102069 cleared October 05, 2010); and Zimmer Unicompartmental Knee System (K033363 cleared January 16, 2004)
21
4
Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with its wings spread, and three wavy lines below the eagle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circle around the eagle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Conformis, Incorporated % Ms. Amita S. Shah Vice President, Quality Assurance and Regulatory Affairs 11 North Ave Burlington, Massachusetts 01803
SEP 6 2012
Re: K121974
Trade/Device Name: ConforMIS® Unicondylar Knee Replacement System (iUni) Regulation Number: 21 CFR 888.3520 Regulation Name: Knee joint femorotibial metal/polymer non-constrained cemented prosthesis Regulatory Class: Class II Product Code: HSX Dated: July 3, 2012 Received: July 9, 2012
Dear Ms. Shah:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
5
Page 2 - Ms. Amita S. Shah
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/deffault.htm
Sincerely yours.
Mark N. Melkerson
Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): _
Device Name:
ConforMIS® Unicondylar Knee Replacement System (iUni)
Indications for Use:
The ConforMIS Unicondylar Knee Replacement System (iUni) is intended for use in one compartment of the osteoarthritic knee to replace the damaged area of the articular surface in patients with evidence of adequate healthy bone sufficient for support of the implanted components.
Candidates for unicondylar knee replacement include those with:
- joint impairment due to osteoarthritis or traumatic arthritis of the knee, ●
- previous femoral condyle or tibial plateau fracture, creating loss of function, .
- valgus or varus deformity of the knee, .
- revision procedures provided that anatomic landmarks necessary for alignment � and positioning of the implant are identifiable on patient imaging scans.
This implant is intended for cemented use only.
Prescription Use X
(Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) mxm ditional 510(k) - Conformis Tom KRS - Clarification of Indications For Use Statement 17